![Patrick Taylor Horn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Taylor Horn
No open positions remaining
Profile
Patrick Taylor Horn formerly worked at Abbott Laboratories, as Medical Director & Head-Clinical Pharmacology in 2006, Dyax Corp., as Vice President-Clinical & Medical Affairs in 2010, Tetraphase Pharmaceuticals, Inc., as Chief Medical Officer from 2011 to 2017, Orphan Technologies Ltd., as Senior VP-Medical & Clinical Development in 2018, Albireo Pharma, Inc., as Chief Medical Officer from 2018 to 2021, HemoShear Therapeutics, Inc., as Chief Medical Officer, and Fulcrum Therapeutics, Inc., as Chief Medical Officer.
Dr. Horn received his doctorate degree from The University of Chicago, undergraduate degree from the University of Illinois, and doctorate degree from Pritzker School of Medicine.
Former positions of Patrick Taylor Horn
| Companies | Position | End |
|---|---|---|
| ALBIREO PHARMA, INC. | Chief Tech/Sci/R&D Officer | 31/12/2021 |
Orphan Technologies Ltd.
 Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs | Corporate Officer/Principal | 01/07/2018 |
| TETRAPHASE PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 29/12/2017 |
| DYAX CORP. | Chief Tech/Sci/R&D Officer | 01/12/2010 |
| ABBOTT LABORATORIES | Chief Tech/Sci/R&D Officer | 01/01/2006 |
Training of Patrick Taylor Horn
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel antibiotics | Health Technology |
HemoShear Therapeutics, Inc.
 HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services Creates human relevant systems that replicate the biology of organ systems and diseases | Health Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pritzker School of Medicine
 Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orphan Technologies Ltd.
Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs | Health Technology |
Fulcrum Therapeutics, Inc.
 Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
- Stock Market
- Insiders
- Patrick Taylor Horn
Choose MarketScreener 
